To Evaluate the Pharmacokinetics and Safety of TQ05105 Tablet in Hepatic Impairment Subjects

Abroad (travel likely)RecruitingPHASE1

Conditions

Myelofibrosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The First Affiliated Hospital of Henan University of Science & Technology, Luoyang, Henan, China
Contact: Study coordinator (Caie Wang, Doctor) · 245454618@qq.com · 13837915297
The First Affiliated Hospital of Shandong First Medical University (Qianfoshan Hospital), Jinan, Shandong, China
Contact: Study coordinator (Wei Zhao, Doctor) · zhao4wei2@hotmail.com · 0531-85875449

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of TQ05105 Tablets in Subjects With Intermediate/High-risk Myelofibrosis

Myelofibrosis

Abroad (travel likely)RecruitingPHASE2

Hefei, China · Fuzhou, China

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive · Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE1

Duarte, United States · Atlanta, United States

Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant

Acute Myeloid Leukemia · Myelodysplastic Syndromes · Chronic Myelomonocytic Leukemia

Abroad (travel likely)RecruitingEARLY_PHASE1

Rochester, United States

Therapeutic RSK1 Targeting in Myelofibrosis

Myelofibrosis

Abroad (travel likely)RecruitingPHASE1

St Louis, United States